Scientists are constantly trying to develop treatments for diseases that can have fatal consequences. A method that has been studied for more than a decade and involves lymph nodes is one of them. This treatment aims to resolve end-stage liver diseases. Now a very important development has taken place regarding this treatment. Developer LyGenesis announced that the first human experiment has officially started.

The method developed by LyGenesis turns lymph nodes into the liver. This comes from a donated liver by taking healthy cells and injecting them into the lymph nodes It’s happening. The cells are filtered and transferred to the lymph nodes to remove things like viruses that cause infections. After this, the cells in the glands must grow, divide and connect to the circulatory system. Eventually the lymph node disappears. a miniature organ it comes out.

The treatment aims to resolve diseases by transforming lymph nodes into the liver

The procedure had been tested on animals for some time. pigs Successful results were seen in the experiments conducted with it. The researchers surgically modified pig livers to mimic human liver disease and transplanted healthy liver samples into lymph nodes. As a result of these mini livers being added to the 6 pigs in the experiment, signs of improvement in liver failure was seen.

Now human experimentation has officially begun. The company’s co-founder and CEO, Dr. Michael Hufford in a clinical trial They dosed the first patient announced and announced that they had broken new ground.

The effects of this cell therapy on safety and efficacy will be observed in human trials involving up to twelve people. All of these patients have end-stage liver disease. At this stage, the liver is in a condition that cannot be repaired and organ transplantation is often required. But even this does not happen because some patients cannot undergo surgery.

It can also eliminate the problem of organ transplantation

The new treatment also has the potential to solve the problem of waiting for a transplant. Nowadays, the number of people waiting for a liver transplant is quite high. For example, in the US there are 10,000 people waiting for donations and the wait time for donations is up to 5 years can get out. It is estimated that 12% of these people will die every year. LyGenesis says that once it gets approval from agencies like the U.S. Drug Administration and is successful in trials, it could treat dozens of patients with a single liver and eliminate the problem of transplants.

We will have to wait a little longer for the results of human experiments. Researchers will follow the patients for a year. The most appropriate dose, reliability and suitability of the treatment are checked. We hope that there will be successful results.